THE BUCK INSTITUTE, WHERE THE PROMISE OF AGING RESEARCH ISN’T LONGEVITY February 15, 2023 The leaders of the Buck Institute for Research on Aging want you to know that they’re not going to make you immortal. Even if they could, they wouldn’t necessarily want...
Scientists look to grow 'mini livers' for patients with organ damage February 15, 2023 It sounds like science fiction: people with end-stage liver disease are injected with cells from a donor liver and, in response, their body produces multiple mini livers that keep them healthy. Yet,...
Juvenescence Chairman explains why investing in longevity has the potential to deliver significant financial, personal and humanitarian returns. February 15, 2023 Jim Mellon, Juvenescence Chairman, explains why investing in longevity has the potential to deliver significant financial, personal and humanitarian returns. “There’s a lot of great stuff happening, but it’s not...
Can achieving beneficial ketone levels improve metabolic health in the military? February 15, 2023 A series of upcoming studies will explore whether the grind of active-duty military life and veterans’ disproportionately high incidence of chronic illness could be tamed by lifestyle interventions designed to...
This company is about to grow new organs in a person for the first time February 15, 2023 LyGenesis hopes to save people with devastating liver diseases who are not eligible for transplants. Their approach is to inject liver cells from a donor into the lymph nodes of...
Chrysea – delivering precision, healthy lifespan nutritional intervention based on credible scientific evidence February 15, 2023 Longevity Technology sits down with Chrysea CEO, Pedro de Noronha Pissarra to talk about the company, its raise and its IP.
The Simple Biotech Podcast: ‘Investing in the Longevity Industry: The Greatest Investment Opportunity in Human History’ February 15, 2023 Dr. Greg Bailey, MD, CEO of Juvenescence discusses innovations in the longevity space in this interview with host James Ruhle of ‘The Simple BioTech Podcast’.
Master Investor 2022: Our CEO, Dr. Greg Bailey, presents Juvenescence February 15, 2023 Master Investor is one of the leading investor meetings. Our CEO and co-founder gives his views on the future of longevity science, investments that will fund progress, and Juvenescence's role...
Longevity Technology: A new era of healthspan and longevity: Longevity supplements February 15, 2023 Juvenescence’s new breakthrough C6 Ketone Di-ester product, a GRAS (Generally Recognized as Safe) ingredient, was highlighted in Longevity Technology’s inaugural report, “A new era of healthspan and longevity: Longevity supplements.”...
Buck Institute to study ketone esters and aging February 15, 2023 Our partner, the Buck Institute for Research on Aging launched an investigational study on ketones to ascertain how they may support aging. “This is a landmark event at the Buck Institute. It’s...
Juvenescence and Buck Institute Set the (ke)tone for Metabolism Research April 22, 2022 Dr Brianna Stubbs discusses ketosis research and a new webinar that features leading experts in the ketone metabolism research field.
Shape: Keto, Your Energy Levels, and Working Out February 07, 2022 Juvenescence partnered with Shape to produce this guide to ketosis. Learn how best to tweak your ketosis to impact results.
